Post-earnings recap
Reported
Thu, Feb 12, 2026
EPS actual
$2.51
EPS est.
$2.57
EPS surprise
-2.33%
1-day move
-0.43%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Rad's earnings report showed a slight miss on EPS, which contributed to a minor decline in stock price. Investors may be concerned about the company's ability to meet expectations in a challenging market. The lack of guidance further adds to uncertainty regarding future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.51 | N/A | -2.33% |
Overall, management expressed a cautious outlook, highlighting the need to navigate market challenges while maintaining focus on future growth.
Management noted challenges in the current market environment.
They emphasized a focus on long-term growth despite short-term pressures.